Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Z-IETD-FMK: Caspase-8 Inhibitor for Apoptosis and Immune ...

    2025-12-20

    Z-IETD-FMK: Caspase-8 Inhibitor for Apoptosis and Immune Modulation

    Executive Summary: Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) is a highly specific, irreversible inhibitor of caspase-8, effectively blocking apoptotic signaling and downstream protease activation in mammalian cells (APExBIO). At concentrations around 100 μM, it suppresses T cell proliferation induced by mitogens and modulates NF-κB p65 nuclear translocation without affecting resting T cells or normal cell growth (Padia et al. 2025). Z-IETD-FMK is widely used in both in vitro and in vivo models for immune modulation, apoptosis pathway inhibition, and inflammatory disease research (malotilate.com). The compound is insoluble in ethanol and water but highly soluble in DMSO (≥32.73 mg/mL), with stock solutions recommended for storage below -20°C. APExBIO provides Z-IETD-FMK (B3232) with comprehensive technical documentation for reproducible results.

    Biological Rationale

    Caspase-8 is a cysteine protease that initiates the extrinsic apoptosis pathway via death receptor signaling. Its activation leads to proteolytic cascades involving downstream caspases such as caspase-3 and caspase-7, ultimately causing cell death (Padia et al. 2025). In immune cells, caspase-8 also regulates T cell proliferation and modulates inflammatory responses through NF-κB signaling. Dysregulation of caspase-8 activity is implicated in cancer, autoimmunity, and inflammatory diseases. Z-IETD-FMK enables specific inhibition of caspase-8, allowing precise dissection of apoptotic and immune signaling events. This is particularly relevant for studies aiming to distinguish between caspase-dependent and -independent cell death pathways (pyronaridinetetraphosphate.com), extending upon prior reviews by detailing quantitative inhibition parameters.

    Mechanism of Action of Z-IETD-FMK

    Z-IETD-FMK is a cell-permeable, peptide-based inhibitor that covalently and irreversibly binds to the catalytic cysteine residue in the active site of caspase-8. The FMK (fluoromethylketone) moiety forms a stable thioether adduct, preventing substrate binding and proteolytic activity. This blockade halts the cleavage of procaspase-8 and its downstream targets, including procaspases-3, -2, and -9, and poly(ADP-ribose) polymerase (PARP). The specificity of Z-IETD-FMK for caspase-8 is conferred by its peptide backbone, which mimics the preferred IETD recognition motif of caspase-8. In contrast to pan-caspase inhibitors, Z-IETD-FMK does not significantly inhibit caspase-1 (involved in pyroptosis) or caspase-4/5/11 under standard conditions, thus providing selectivity for apoptosis pathway interrogation (Padia et al. 2025).

    Evidence & Benchmarks

    • Z-IETD-FMK (100 μM) suppresses T cell proliferation in response to phytohemagglutinin (PHA) or anti-CD3/anti-CD28 stimulation, but does not affect resting T cells (Padia et al. 2025).
    • In cancer cell lines, Z-IETD-FMK prevents TRAIL-mediated apoptosis by protecting procaspases-9, -2, -3, and PARP from cleavage (Padia et al. 2025).
    • Z-IETD-FMK reduces nuclear translocation of the NF-κB p65 subunit in activated T cells at effective concentrations (100 μM), suggesting interference with pro-inflammatory transcriptional programs (Padia et al. 2025).
    • Compound solubility is ≥32.73 mg/mL in DMSO at room temperature, but Z-IETD-FMK is insoluble in water and ethanol (APExBIO).
    • Stock solutions remain stable below -20°C for short-term use; repeated freeze-thaw cycles should be avoided for optimal activity (APExBIO).

    This article extends the review in malotilate.com by providing updated quantitative solubility and storage parameters, supporting more reproducible experimental design.

    Applications, Limits & Misconceptions

    Z-IETD-FMK is widely applied in apoptosis research, T cell proliferation inhibition, NF-κB signaling studies, and in vivo immune modulation models. Its use allows for clear attribution of phenotypes to caspase-8 activity. Below are common boundaries and misconceptions:

    Common Pitfalls or Misconceptions

    • Not a pan-caspase inhibitor: Z-IETD-FMK shows minimal activity against caspase-1, 3, or 9 at standard concentrations, contrasting with broader-spectrum FMK inhibitors (Padia et al. 2025).
    • Does not induce cell death: Z-IETD-FMK itself does not trigger apoptosis or pyroptosis; it is an inhibitor used to block these pathways.
    • Ineffective in water/ethanol: The compound is insoluble in aqueous or ethanol solutions, so DMSO must be used as the solvent.
    • Not for chronic in vivo dosing: Most published protocols use Z-IETD-FMK for acute or short-term treatments due to potential DMSO toxicity and irreversible inhibition.
    • Cannot block pyroptosis: Z-IETD-FMK does not inhibit caspase-1-dependent pyroptosis, as shown in HOXC8 studies and inflammasome research (Padia et al. 2025).

    This article clarifies distinctions noted in z-wehd-fmk.com by specifying Z-IETD-FMK's caspase selectivity and boundaries in pyroptosis models.

    Workflow Integration & Parameters

    For cell culture studies, Z-IETD-FMK is typically prepared as a 10–20 mM stock in DMSO and diluted to final concentrations of 10–100 μM in culture medium. Solutions should be freshly prepared or stored at -20°C; avoid repeated freeze-thaw cycles. For in vivo experiments, dosing regimens are tailored based on the animal model and should not exceed vehicle (DMSO) toxicity thresholds. Z-IETD-FMK is compatible with flow cytometry, immunoblotting, and cell viability assays. It is most effective when used prior to or concurrent with pro-apoptotic or pro-inflammatory stimuli. The product page (APExBIO) provides validated protocols and troubleshooting guidance.

    This technical overview updates the workflow focus of 2xpowderblend.com by emphasizing solvent compatibility and short-term storage for optimal caspase-8 inhibition.

    Conclusion & Outlook

    Z-IETD-FMK, as supplied by APExBIO, remains the reference caspase-8 inhibitor for apoptosis and immune cell signaling research due to its selectivity, potency, and robust documentation. It enables precise dissection of the caspase signaling pathway and immune cell activation phenomena. Future research may further delineate its role in inflammatory models and extend its use to engineered immune cell systems. The product's reliability and specificity facilitate experimental reproducibility and translational study design. For detailed protocols, benchmarks, and ordering information, see the Z-IETD-FMK product page.